Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 25:13:852416.
doi: 10.3389/fimmu.2022.852416. eCollection 2022.

Crosstalk Between the Oxidative Stress and Glia Cells After Stroke: From Mechanism to Therapies

Affiliations
Review

Crosstalk Between the Oxidative Stress and Glia Cells After Stroke: From Mechanism to Therapies

Ganggui Zhu et al. Front Immunol. .

Abstract

Stroke is the second leading cause of global death and is characterized by high rates of mortality and disability. Oxidative stress is accompanied by other pathological processes that together lead to secondary brain damage in stroke. As the major component of the brain, glial cells play an important role in normal brain development and pathological injury processes. Multiple connections exist in the pathophysiological changes of reactive oxygen species (ROS) metabolism and glia cell activation. Astrocytes and microglia are rapidly activated after stroke, generating large amounts of ROS via mitochondrial and NADPH oxidase pathways, causing oxidative damage to the glial cells themselves and neurons. Meanwhile, ROS cause alterations in glial cell morphology and function, and mediate their role in pathological processes, such as neuroinflammation, excitotoxicity, and blood-brain barrier damage. In contrast, glial cells protect the Central Nervous System (CNS) from oxidative damage by synthesizing antioxidants and regulating the Nuclear factor E2-related factor 2 (Nrf2) pathway, among others. Although numerous previous studies have focused on the immune function of glial cells, little attention has been paid to the role of glial cells in oxidative stress. In this paper, we discuss the adverse consequences of ROS production and oxidative-antioxidant imbalance after stroke. In addition, we further describe the biological role of glial cells in oxidative stress after stroke, and we describe potential therapeutic tools based on glia cells.

Keywords: astrocyte; microglia; oxidative stress; stroke; therapies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The main mechanisms of ROS production after stroke. Electrons released from the electron transport chain (ETC) react with O2 to produce superoxide. Mitochondrial complexes, oxidases in the matrix, and NADPH oxidase are involved in the release of ROS. Ca2+, NO, and succinate produced by the TCA cycle are important contributing factors. O2 is catalyzed by SOD to produce H2O2, which can be decomposed into H2O and O2. NO can combine with O2 to form ONOO-, causing nitrosative stress.
Figure 2
Figure 2
Astrocytes and microglia interact and function together during stroke. Astrocytes release Ca2+, S100B, and cytokines that affect the redox state of microglia. The production of H2O2 and NO by microglia facilitates the activation process of astroglial. Glial cells affect glutamate transport, inflammatory factor secretion, matrix protease activation, and antioxidant production via ROS, which together cause post-stroke excitotoxicity, neuroinflammation, BBB destruction, and neurogenesis.
Figure 3
Figure 3
The relationship between oxidative stress and the Nrf2 signaling pathway in astrocytes. ROS or compounds stimulate Nrf2 transcription into the nucleus and participate in the transcription of target genes. increased synthesis of enzymes such as HO-1, NQO1, GPx, and MRP1 counteract oxidative stress and regulate metabolism. Nrf2 is also involved in regulating inflammatory responses.

References

    1. Boursin P, Paternotte S, Dercy B, Sabben C, Maier B. [Semantics, Epidemiology and Semiology of Stroke]. Soins (2018) 63(828):24–7. doi: 10.1016/j.soin.2018.06.008 - DOI - PubMed
    1. Barthels D, Das H. Current Advances in Ischemic Stroke Research and Therapies. Biochim Biophys Acta Mol Basis Dis (2020) 1866(4):165260. doi: 10.1016/j.bbadis.2018.09.012 - DOI - PMC - PubMed
    1. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and Regional Burden of Stroke During 1990-2010: Findings From the Global Burden of Disease Study 2010. Lancet (2014) 383(9913):245–54. doi: 10.1016/S0140-6736(13)61953-4 - DOI - PMC - PubMed
    1. Belur PK, Chang JJ, He S, Emanuel BA, Mack WJ. Emerging Experimental Therapies for Intracerebral Hemorrhage: Targeting Mechanisms of Secondary Brain Injury. Neurosurg Focus (2013) 34(5):E9. doi: 10.3171/2013.2.FOCUS1317 - DOI - PubMed
    1. Islam MT. Oxidative Stress and Mitochondrial Dysfunction-Linked Neurodegenerative Disorders. Neurol Res (2017) 39(1):73–82. doi: 10.1080/01616412.2016.1251711 - DOI - PubMed

Publication types

MeSH terms